Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 10, 2019 |
| Target | RHOFADE |
| Sector | Life Science |
| Buyer(s) | EPI Health |
| Sellers(s) | Aclaris |
| Deal Type | Divestiture |
FILTER BY
| Category | Company |
|---|---|
| Founded | 2017 |
| Sector | Life Science |
EPI Health is an established dermatology specialty company that has launched and markets innovative prescription therapies to dermatologists to improve patients’ quality of life. It is one of the fastest-growing companies in the US dermatology community. EPI Health was founded in 2017 and is based in Charleston, South Carolina.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| State: Pennsylvania | 1 of 1 |
| Country: United States | 1 of 1 |
| Year: 2019 | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 2012 |
| Sector | Life Science |
| Employees | 61 |
| Revenue | 19M USD (2024) |
Aclaris is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated drugs to address significant unmet needs in dermatology. Aclaris was founded in 2012 and is based in Wayne, Pennsylvania.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| State: Pennsylvania | 1 of 1 |
| Country: United States | 1 of 1 |
| Year: 2019 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-08-08 |
Confluence Life Sciences
Saint Louis, Missouri, United States Confluence Life Sciences, Inc. is a privately held biotechnology company focused on the discovery and development of kinase inhibitors to treat inflammatory and immunological disorders and cancer. Confluence Life Sciences was founded in 2010 and is based in Saint Louis, Missouri. |
Buy | $10M |
